The association made in our cohort, given the strong personal and family histories for aneurysmal and dissection disease, implies that ZNF469 may play a pivotal role in ECM regulation through its downstream regulatory effects on different collagens, Thrombospondin-1, or Clusterin. Here, CLU is linked to glycogen storage disease VI.